Global pharma firms interested in local startup's new glaucoma treatment
Singapore
"FIRST you have my interest, now you have my attention."
And that is what local biotech startup Peregrine Ophthalmic managed to do, in the words of associate professor Tina Wong, who was describing how a new glaucoma drug delivery solution developed by her 15-month-old startup has attracted inquiries from the world's top five pharmaceutical companies.
TRENDING NOW
Haidilao co-founder’s family buys second bungalow in Cluny Hill for S$85 million
Yeo’s, Tiger Beer and now Gardenia – flight of food manufacturing from Singapore might be just as planned
Prabowo’s biggest crackdown on tycoons shocked his own officials
Apex court rejects resulting trust claim in 99-1 condo dispute